依那普利联合螺内酯对慢性心力衰竭患者心功能指标及血流动力学的影响
2019-09-29何国强
何国强



【摘要】 目的:探讨依那普利联合螺内酯对慢性心力衰竭患者心功能指标及血流动力学的影响。方法:选取2017年8月-2018年7月本院收治的慢性心力衰竭患者82例,随机分为对照组与研究组,每组41例。对照组应用常规治疗,研究组在对照组基础上联合依那普利联合螺内酯治疗。比较两组治疗效果、血气指标与心功能指标。结果:研究组治疗效果明显优于对照组(P<0.05);研究组各血气指标均优于对照组(P<0.05);研究组治疗后各心功能指标均优于对照组(P<0.05)。结论:使用依那普利联合螺内酯可有效改善慢性心力衰竭患者心功能,效果显著,有极高的应用价值,值得大力的推广。
【关键词】 依那普利联合螺内酯; 慢性心力衰竭; 心功能指标; 血流动力学
Effects of Enalapril Combined with Spironolactone on Cardiac Function and Hemodynamics in Patients with Chronic Heart Failure/HE Guoqiang.//Medical Innovation of China,2019,16(18):-120
【Abstract】 Objective:To explore the effects of Enalapril combined with Spironolactone on cardiac function and hemodynamics in patients with chronic heart failure.Method:A total of 82 cases of patients with chronic heart failure admitted to our hospital from August 2017 to July 2018 were selected and randomly divided into control and study groups,41 cases in each group.The control group was treated with conventional therapy.The study group was treated with Enalapril combined with Spironolactone on the basis of the control group.The treatment effect,blood gas index and cardiac function index of the two groups were compared.Result:The treatment effect of the study group was significantly better than that of the control group(P<0.05).The each blood gas index in the study group were better than those in the control group(P<0.05).All cardiac function indexes of the study group after treatment were better than those of the control group(P<0.05).Conclusion:The Enalapril combined with Spironolactone can effectively improve cardiac function of patients with chronic heart failure with with remarkable effects and high application value.It is worthy promoting.
【Key words】 Enalapril combined with Spironolactone; Chronic heart failure; Cardiac function index;Hemodynamics
First-authors address:Qianjiang Central Hospital,Qianjiang 433100,China
doi:10.3969/j.issn.1674-4985.2019.18.031
慢性的心力衰竭屬于目前表现极复杂,危害人类生命安全的疾病一种,是各类心血管疾病发展的终末时期。由于人们的经济水平不断地发展,生活的习惯同样随着改变,慢性心力衰竭发病率,随之增多,此疾病死亡率越来越高,患者生命安全受到极大地威胁[1]。目前多表现为心脏的排出量不足、灌注血液的组织减少、静脉系统循环的淤血状态,对患者的生活造成极大不便。症状严重可能会导致患者困难呼吸、乏力及体液潴留等状态发生,同时还会出现急性的左心衰以及心律失常,严重可导致猝死,临床中的危害特别大,需引起医学人员的高度的重视[2]。近年来,该疾病的治疗在医学中逐渐有了新的进展,心力衰竭的发生、发展与机体的血脂异常、炎症反应和氧化应激状态有明显的相关作用[3]。所以对患者血脂水平进行改善,减轻炎症反应和缓解应激氧化状态,属于治疗慢性心力衰竭的主要因素。运用依那普利联合螺内酯治疗慢性心力衰竭,能对患者血脂进行调节,改善氧化应激状态,阻止炎症的过激反应作用[4]。……
